AIM: To report the long-term effect of stent placement in 115 patients with Budd-Chiari syndrome (BCS). METHODS: One hundred and fifteen patients with BCS were treated by percutaneous stent placement. One hundred and two patients had IVC stent placement, 30 patients had HV stent placement, 17 of them underwent both IVC stent and HV stent. All the procedures were performed with guidance of ultrasound. RESULTS: The successful rates in placing IVC stent and HV stent were 94% (96/102) and 87% (26/30), respectively. Ninety-seven patients with 112 stents (90 IVC stents, 22 HV stents) were followed up. 96.7% (87/90) IVC stents and 90.9% (20/22) HV stents remained patent during follow up periods (mean 49 months, 45 months, respectively). Five of 112 stents in the 97 patients developed occlusion. Absence of anticoagulants after the procedure and types of obstruction (segmental and occlusive) before the procedure were related to a higher incidence of stent occlusion. CONCLUSION: Patients with BCS caused by short length obstruction can be treated by IVC stent placement, HV stent placement or both IVC and HV stent placement depending on the sites of obstruction. The long-term effect is satisfactory. Anticoagulants are strongly recommended after the procedure especially for BCS patients caused by segmental occlusion.
AIM: To report the long-term effect of stent placement in 115 patients with Budd-Chiari syndrome (BCS). METHODS: One hundred and fifteen patients with BCS were treated by percutaneous stent placement. One hundred and two patients had IVC stent placement, 30 patients had HV stent placement, 17 of them underwent both IVC stent and HV stent. All the procedures were performed with guidance of ultrasound. RESULTS: The successful rates in placing IVC stent and HV stent were 94% (96/102) and 87% (26/30), respectively. Ninety-seven patients with 112 stents (90 IVC stents, 22 HV stents) were followed up. 96.7% (87/90) IVC stents and 90.9% (20/22) HV stents remained patent during follow up periods (mean 49 months, 45 months, respectively). Five of 112 stents in the 97 patients developed occlusion. Absence of anticoagulants after the procedure and types of obstruction (segmental and occlusive) before the procedure were related to a higher incidence of stent occlusion. CONCLUSION:Patients with BCS caused by short length obstruction can be treated by IVC stent placement, HV stent placement or both IVC and HV stent placement depending on the sites of obstruction. The long-term effect is satisfactory. Anticoagulants are strongly recommended after the procedure especially for BCS patients caused by segmental occlusion.
Authors: A R Rao; A K Chui; A Gurkhan; L W Shi; I Al-Harbi; R Waugh; D J Verran; G W McCaughan; D Koorey; A G Sheil Journal: Transplant Proc Date: 2000-11 Impact factor: 1.066
Authors: Z Chunqing; F Lina; Z Guoquan; X Lin; W Zhaohai; J Tao; Q Chengyong; Z Juzhen Journal: J Vasc Interv Radiol Date: 1999 Jul-Aug Impact factor: 3.464
Authors: Antonia Perelló; Juan Carlos García-Pagán; Rosa Gilabert; Yanette Suárez; Eduardo Moitinho; Francisco Cervantes; Juan Carlos Reverter; Angels Escorsell; Jaume Bosch; Juan Rodés Journal: Hepatology Date: 2002-01 Impact factor: 17.425
Authors: Manfred Cejna; Markus Peck-Radosavljevic; Maria Schoder; Siegfried Thurnher; Ahmed Ba-Ssalamah; Bernhard Angermayr; Klaus Kaserer; Boris Pokrajac; Johannes Lammer Journal: J Vasc Interv Radiol Date: 2002-02 Impact factor: 3.464
Authors: J B Dilawari; P Bambery; Y Chawla; U Kaur; S R Bhusnurmath; H S Malhotra; G K Sood; S K Mitra; S K Khanna; B S Walia Journal: Medicine (Baltimore) Date: 1994-01 Impact factor: 1.889
Authors: Nitin Jagtap; Mithun Sharma; Jagdeesh Singh; Manu Tandan; P N Rao; Rajesh Gupta; Sundeep Lakhtakia; Mohan Ramchandani; Harshal Shah; T Mahesh Kumar; Santosh Darishetty; G V Rao; D N Reddy Journal: Indian J Gastroenterol Date: 2017-06-20